Actively Recruiting
MEthylphenidate in ADHD - Addiction(s) Comorbidity: Value of Adding a Cognitive Remediation Program to Improve Short- and Medium-term Therapeutic Response
Led by Nantes University Hospital · Updated on 2026-02-19
248
Participants Needed
6
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
MEthylphenidate in ADHD - Addiction(s) comorbidity: benefit of adding a cognitive remediation program to improve short- and medium-term therapeutic response
CONDITIONS
Official Title
MEthylphenidate in ADHD - Addiction(s) Comorbidity: Value of Adding a Cognitive Remediation Program to Improve Short- and Medium-term Therapeutic Response
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 18
- Confirmed diagnosis of ADHD by DIVA-5 interview in a specialized ADHD-addiction consultation
- Indication for methylphenidate treatment according to European guidelines and no cardiological contraindications
- Presence of at least one comorbid addictive disorder (substance use disorder or behavioral addiction)
- Provided consent to participate in the study
- Affiliated with or benefiting from the French social security system
You will not qualify if you...
- Disorders or difficulties in reading or writing French that prevent data collection
- Pregnant or breastfeeding women
- Persons deprived of liberty
- Persons under compulsory psychiatric care
- Participation in another interventional research protocol with psychotherapeutic or pharmacological treatment affecting clinical outcome
- Under guardianship or safeguard of justice
- Consumed psychoactive substances within 12 hours before their visit
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
CHRU Brest
Brest, Brittany Region, France, 29609
Not Yet Recruiting
2
EPSM du Finistère Sud
Quimper, Brittany Region, France, 29000
Not Yet Recruiting
3
EPSM Georges Daumézon (Fleury-les-Aubrais, Loiret)
Fleury-les-Aubrais, Centre-Val de Loire, France, 45400
Not Yet Recruiting
4
CHRU de Tours
Tours, Centre-Val de Loire, France, 37000
Not Yet Recruiting
5
CH Georges Daumézon - Bouguenais
Bouguenais, Loire-Atlantique, France, 44342
Not Yet Recruiting
6
CHU Nantes
Nantes, France
Actively Recruiting
Research Team
C
Clémence Dr Cabelguen, MD-Phd
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here